424B3 1 d315806d424b3.htm 424B3 424B3

Filed pursuant to Rule 424(b)(3)

Registration Statement No. 333-260652

Prospectus Supplement No. 4

(To Prospectus dated November 12, 2021)

Wallbox N.V.

This prospectus supplement updates, amends and supplements the prospectus dated November 12, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form F-1 (Registration No. 333-260652). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with our unaudited first quarter of 2022 financial results, which are set forth below.

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

Wallbox N.V.’s Class A ordinary shares and warrants are quoted on the New York Stock Exchange under the symbol “WBX” and WBXWS, respectively. On May 10, 2022, the closing price of our Class A ordinary share was $11.56, and the closing price for our warrants was $2.30.

INVESTING IN OUR SECURITIES INVOLVES CERTAIN RISKS. SEE “RISK FACTORS” BEGINNING ON PAGE 16 OF THE PROSPECTUS.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is May 11, 2022.


FINANCIAL HIGHLIGHTS

Financial & Operating Highlights: Q1 2022

 

INCOME STATEMENT     BALANCE SHEET      OPERATING METRICS  
(€ IN MILLIONS)     (€ IN MILLIONS)         

Revenue

   28,263           Units sold      ~51,000  
     Cash & Equivalents    157,569        
           Headcount      ~1,000  

YoYGrowth

     192   LT Debt    23,465        
           Countries      +100  

Gross Margin

     41.4         2022 Est. Mfg. Capacity      +1,000,000  

Reconciliations

Unaudited, in € 000s

 

     For the Quarter Ended,
March 31,
 
     2022  

Operating Loss

   (19,417

Amortization and depreciation

     3,934  

Other income

     (292
  

 

 

 

EBITDA

   (15,774

Employee Stock Option Plan

     —    

One-off Expenses

     123  
  

 

 

 

Adjusted EBITDA

   (15,652